Lech CISZEWSKI,Marilyn DE LA CRUZ,Piotr H. KARPINSKI,Michael MUTZ,Christian RIEGERT,Caspar VOGEL,Ricardo SCHNEEBERGER
申请号：
US15799235
公开号：
US20180118678A1
申请日:
2017.10.31
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This invention relates to a hemifumarate salt of 1-(4- 1-[(E)-cyclohexyl-3-tritluoromethy 1-benzy loxyimino ]-ethy 1)-2-ethy1-benzy l)-azetidine-3-carboxy lie acid (Compound) to pharmaceutics compositions comprising this salt, to processes for forming this salt and to its use in medical treatment, addition, the present invention also relates to new polymorphic forms of the hemifumarate salt form of Compound I, as well as to pharmaceutical compositions comprising these polymorphic forms, to processes for obtaining them, and their use in medical treatment.
